Wooin Lee

seoul national university

H指数:39

被引数:6,558

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-species assessment of propranolol pharmacokinetics via minimal and whole-body PBPK modeling

通过最小化和全身体积血液灌注模型对普萘洛尔药代动力学的多物种评估

Frontiers in Pharmacology

IF4.8

2026-09-100

In vivo and in vitro assessment of absorption and disposition kinetics of bis[2-(perfluorohexyl)ethyl] phosphate in rats: food effect, physiologically-based modeling, and human exposure estimation

大鼠体内和体外对双[2-(全氟己基)乙基]磷酸酯吸收和分布动力学的评估：食物效应、生理学基础建模及人体暴露评估

Environment International

IF9.7

2026-08-010

PRE

Metabolic fate and oral dosing feasibility of the formyl peptide receptor 2 agonist WKYMVm: An integrated analytical and kinetic modeling approach

甲酰化肽受体2激动剂WKYMVm的代谢命运与口服给药可行性：一种整合分析方法和动力学建模的方法

European Journal of Pharmaceutical Sciences

IF4.7

2026-06-060

OAAI

Neutrophil-Like Mitochondria Enable Blood–Brain Barrier Transmigration and Neuroprotection

中性粒细胞样线粒体促进血脑屏障转位迁移和神经保护

ACS Nano

IF16

2026-05-180

PRE

Development of a quantitative LC-MS/MS-based assay for Lycosin–II–analog 3 and assessment of its stability in biological matrices

基于LC-MS/MS的Lycosin–II–analog 3定量检测方法的开发及其在生物基质中的稳定性评估

Talanta

IF6.1

2026-04-280

PRE

Evaluation of serum amyloid A as a biomarker for sepsis diagnosis compared with C-reactive protein, procalcitonin, and presepsin

金明浩、姜世英、李文一、李明英. 血清淀粉样蛋白A作为脓毒症诊断生物标志物的评价，与C反应蛋白、降钙素原和可溶性CD14短片段的比较. 实验室医学, 2026, 57, lmaf054. [Google Scholar] [CrossRef] [PubMed]

Laboratory Medicine

IF1

2026-03-011

PRE

Gut bacterial O-demethylation modulates systemic exposure to oral etoposide

肠道细菌的去甲基化作用调节口服依托泊苷的系统暴露

Gut Microbes

IF11

2026-02-130

Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics

同时进行非那雄胺和度他雄胺的靶点介导药物处置-药效学（TMDD-PD）建模：靶点结合和转换对非线性药代动力学的影响

The AAPS Journal

IF0

2025-12-090

PRE

Hydroxylation near the epoxyketone of carfilzomib confers protection from microsomal epoxide hydrolase-mediated metabolism

卡非佐米(epoxideketone)附近的羟基化赋予其抵抗微粒体环氧水解酶介导的代谢的保护作用

Drug Metabolism and Disposition

IF4

2025-06-250

PRE

GC1126A, a novel ADAMTS13 mutein, evades autoantibodies in immune-mediated thrombotic thrombocytopenic purpura

SCIENTIFIC REPORTS

IF3.9

2025-01-100

OAAI

Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2024-07-230

OAAI

Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer's Disease (vol 64, pg 10934, 2021)

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-03-120

Nonclassical Arylative Meyer-Schuster Rearrangement through Ni-Catalyzed Inner-Sphere Acyloxy Migration

ACS CATALYSIS

IF13.1

2023-08-015

PRE

Size optimization of carfilzomib nanocrystals for systemic delivery to solid tumors

用于全身递送至实体瘤的carfilzomib纳米晶体的尺寸优化

JOURNAL OF CONTROLLED RELEASE

IF11.5

2022-12-018

OAAI

Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in vitro and in vivo

PHARMACOLOGY & THERAPEUTICS

IF12.5

2022-01-0121

PREAI

Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer's Disease

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-07-2611

OAAI

Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems

JOURNAL OF PHARMACEUTICAL INVESTIGATION

IF5.1

2021-05-085

PREAI

Relationship between Brain Tissue Changes and Blood Biomarkers of Cyclophilin A, Heme Oxygenase-1, and Inositol-Requiring Enzyme 1 in Patients with Alzheimer's Disease

DIAGNOSTICS

IF3.3

2021-04-215

OAAI

Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (vol 39, pg 4567, 2020)

ONCOGENE

IF7.3

2021-02-110

OAAI

Improved Prediction of the Drug-Drug Interactions of Pemafibrate Caused by Cyclosporine A and Rifampicin via PBPK Modeling: Consideration of the Albumin-Mediated Hepatic Uptake of Pemafibrate and Inhibition Constants With Preincubation Against OATP1B

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2021-01-013

PREAI

Wooin Lee

个人简介

教育背景

工作经历

荣誉奖项

研究方向